Satoshi Tanaka

Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)

Toshitaka Nakamura, Masao Fukunaga, Tsuyoshi Nakano et al. · Osteoporosis International · 2016 · 74 citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +16

Safety, pharmacokinetics, and changes in bone metabolism associated with zoledronic acid treatment in Japanese patients with primary osteoporosis

Masataka Shiraki, Satoshi Tanaka, Hiroaki Suzuki et al. · Journal of Bone and Mineral Metabolism · 2016 · 20 citations

Medicine, Pharmacokinetics, Pharmacology +12

Acute Phase Reactions After Intravenous Infusion of Zoledronic Acid in Japanese Patients with Osteoporosis: Sub-analyses of the Phase III ZONE Study

Masataka Shiraki, Tatsuhiko Kuroda, Yasuhiro Takeuchi et al. · Calcified Tissue International · 2021 · 20 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Improved periodontal disease and prevention of tooth loss in osteoporosis patients receiving once-yearly zoledronic acid: a randomized clinical trial

Akira Taguchi, Masataka Shiraki, Satoshi Tanaka et al. · Menopause The Journal of The North American Menopause Society · 2019 · 18 citations · Full text

Dentistry, Oral Health Sciences, Periodontics +17

Memantine for the patients with mild cognitive impairment in Parkinson’s disease: a pharmacological fMRI study

Shoji Kawashima, Yoko Shimizu, Mitsuya Horiba et al. · BMC Neurology · 2022 · 17 citations · Full text

Medicine, Neurology, Pharmacology +17